Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma.

Bibliographic Details
Published in:Journal of Clinical Oncology Vol. 44; pp. 374 - 561
Main Authors: Zhen, David Bing, Maziarz, Richard T., Chen, Emerson Yu-sheng, Fountzilas, Christos, Kim, Dae Won, Gutierrez, Martin, Gibson, Michael K., DeVito, Nicholas C., Phan, Alexandria T., Oshrine, Benjamin, Koneru, Mythili, Vahora, Sahista, Wang, Chuan, Xin, Lijun, Davis, Christian, Zhang, Jinghui, Shields, Anthony F.
Format: Journal Article
Published: American Society of Clinical Oncology 2026 Supplsmsnr 2
Online Access:View this record in EBSCOhost